AGL vs LRCX · rev $2.92B vs P/E 71, rev $23.23B
agilon health Inc (AGL) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
agilon health Inc (AGL) is a medical care facilities company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported AGL revenue for 2026-06-30 was $2.92B. Net income was $66.9M. AGL currently screens at market cap $1.45B.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
AGL currently screens at market cap $1.45B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the AGL and LRCX stock pages for the full models.
Not investment advice.